Application Notes and White Papers
Customer application notes
If you would like to co-publish an application note with Arrayjet, we would be pleased to support you with your project. Contact our microarray experts to discuss your ideas.
Protein and DNA microarrays are the key strengths of Arrayjet technology. The antibody microarray application note highlights the reproducible printing of fluorescence-labelled antibodies onto functionalised glass slides to produce high-quality arrays.
The production of carbohydrate microarrays presents unique challenges and extraction solvents can be very harsh. Arrayjet technology is suited to printing samples with vastly different chemical and physical properties and as such, it is the first choice for many principle investigators in carbohydrates research. The carbohydrate application note demonstrates this versatility.
Assessment of printing reproducibility
Arrayjet instruments are built with a strong focus on quality control and spot consistency. The application note on printing reproducibility provides evidence of reliability across slide batches printed using Arrayjet microarrayers.
By not coming into contact with the substrate, Arrayjet instruments can be used to print onto a variety of substrates as detailed in the microplate printing application note. The non-contact sample deposition is also ideally-suited for protein microarray printing onto delicate nitrocellulose and hydrogel surfaces.
Arrayjet has optimised methods of preventing sample evaporation during long print runs. The JetGuard™ forms a seal in every single well of a 384 microplate. Samples are protected against airborne contaminants and sample plates can be reused to produce reliable microarrayers.
Compound library screening application note
Arrayjet has developed a method for printing small molecule microarrays using DMSO buffer. Under optimised conditions, spot morphology is excellent.
Antibody specificity testing - white paper
The use of protein microarrays to screen antibodies sets new quality standards for evaluating antibody cross-reactivity. This addresses the need for new methods to identify antibodies that can be used in robust scientific investigations, grant proposals, and for commercialisation.